Isofol initiates data assessment in Phase III colorectal cancer drug trial
Isofol Medical has initiated assessment of results from Phase III AGENT trial of arfolitixorin to treat metastatic colorectal cancer (mCRC).
Stay updated with breaking news from Processing Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Isofol Medical has initiated assessment of results from Phase III AGENT trial of arfolitixorin to treat metastatic colorectal cancer (mCRC).
Smart Card Material Market was valued at US$ 1324.57Mn in 2021 and is expected to grow at a CAGR of 4.8% from 2021 to 2028 to reach US$ 1,837.78Mn by...
AstraZeneca has reported that its Evusheld offered protection against symptomatic Covid-19 for a minimum of six months in Phase III trial.
Poland’s pharma industry registered a 2.1% rises in IT hiring activity in March 2022, according to GlobalData
Unlearn has raised $50m in a Series B financing round led by Insight Partners to advance the use of TwinRCTs in clinical trials.